Although ageing is (still) an inevitable biological process, humans currently are facing an unprecedented increase in their lifespan. However, healthy ageing has a primate above the simple increase in lifespan and thus the current anti-ageing strategies are switching the focus from suppressing ageing to promote successful ageing and healthspan. The main aim is not just to maximize the length of life, but instead to increase the period of life time spent free of detrimental conditions accompanying old age. Discovering fully the fundamental molecular mechanisms and factors underlying the process of ageing and longevity is a pre-requisite for developing appropriate strategies for increasing "healthy lifespan". In this respect ageing research nowadays goes to as during the onset of age-related diseases is of high importance. To fight ageing requires understanding of ageing, and in that battle scientific community should move forward by making many small steps.
A C C E P T E D M A N U S C R I P T several directions: we still elucidate ageing mechanisms, we are seeking for the best model systems for ageing studies, we are trying to find reliable markers that should enable an early detection of an age-related diseases, and finally, we investigate potential anti-ageing strategies.
The recent IUBMB Focused Meeting on "Molecular aspects of ageing and longevity" (October 16th -19th 2017, Athens, Greece) focused exactly on these topics. Herein, we present a Special Issue based on this Meeting addressing some of the most critical aspects in the ageing field.
The answer to the question "why do we age" can only be given if we fully discover cellular mechanisms playing a fundamental role in the ageing process. There are several of them existing in a complex interplay and nematode Caenorhabditis elegans has proven extremely useful in identifying the main transcriptional regulators, longevity-regulating signals, cellular processes, epigenetic modifications and pharmacological agents that have been revealed to govern ageing (Denzel et al.,2018) . In this manner several aspects of mitochondrial metabolism were identified as critical processes of lifespan regulation (Mammucari and Rizzuto, 2010) . FAHD1, a member of the FAH superfamily of enzymes, has been suggested to play a pivotal role in the regulation of mitochondrial function. Pidder Jansen-Dürr and colleagues discuss the role of FAHD1 as a regulator of mitochondrial function in the context of a potentially reversible form of senescence named by the authors as senescence light (Etemad et al., 2018) . On the other hand deregulated activity of SOX2 (Sex-determining region Y box 2), a transcription factor expressed in several fetal and adult tissues, has been linked to age-associated chronic diseases. The expression levels of SOX2 in various rodent and human tissues upon the progression of ageing have been revealed, as well as an inverse correlation of SOX2 expression with p16Ink4a levels. These findings indicated that the diminished SOX2 expression may serve as an ageing marker (Carrasco-Garcia et al., 2018).
Another key player with a critical function in cellular ageing is telomeres/telomerase system. Short telomeres trigger cellular senescence and genomic instability, leading to numerous degenerative and ageing-related diseases. The associations between oxidative stress and accelerated telomere shortening and possible mechanisms and cellular pathways that protect telomeres from oxidative damage have been reviewed by Barnes et al (2018) . The ubiquitinproteasomal-system (UPS) and the autophagy-lysosomal-system (ALS) are other important Dysregulation of nutrient sensing, altered intercellular communication, stem cell exhaustion, loss of proteostasis, and epigenetic alterations were detected as underlying cellular mechanisms for the hypothalamus-mediated ageing, with mTOR, NF-kB, autophagy, and SIRT1 as critical factors in these processes. Further dissection of these pathways or components that would expand the existing knowledge about the ageing process could pave the wave for developing novel therapeutic interventions for numerous age-related diseases (Kim and Choe, 2018).
A significant factor contributing to the ageing process could also be a dysregulation of adaptive homeostasis, especially in the final third of lifespan. Organisms/cells have to cope successfully with a range of intrinsic and extrinsic perturbations to adapt to the ever-changing environment. The term adaptive homeostasis refers to a plethora of transient changes that endows the organism to activate cellular defense pathways and be prepared for future insults. The role of As frailty and loss of resilience represent potential targets for geroprotectors, drugs that modulate mechanisms of ageing and are able to target multiple deficits, appropriate models are extremely important. Modeling resilience in mice can be achieved by several methods. Herein authors review potential models of physical resilience, focusing on those that include sepsis, trauma, drug-and radiation exposure, kidney and brain ischemia, exposure to noise, heat and cold shock, and seeking for those where administration of acute stressors require integrative responses and multiple tissues. Nutrition is in the focus of the review by Green and Lamming (2018). By now it became evident that it is not only the quantity, but also the quality of nutritients that plays a role in metabolic health and disease. Authors discussed recent findings regarding the influence of dietary proteins, specific amino acids and reduction of their content on metabolic health, in a broad spectrum of model organisms, as well as potential molecular mechanisms underlying. It is confirmed that amino acid restriction may promote metabolic health via multiple molecular mechanisms, but with sexually dimorphic response present.
Ageing is a multifactorial process governed by both genetic factors and the exposome. It constitutes a main risk factor for age-and aggregation-related diseases. Its retardation is the holy grail of the field as this would also mean decrease and/or deceleration in the development and progression of age-associated degenerative diseases. With an ever-growing proportion of the elderly, there is an immense pressure to identify strategies to prevent or delay age-associated frailty and disease that is imperative for maintaining the health of the population, as well as global economy. However, in order to develop therapeutic strategies for delaying age-related pathology, a better understanding of the underlying causes of ageing and age-associated diseases is required.
Therefore, elucidation of the regulatory pathways that are activated during normal ageing as well 
